News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Predicted Growth for In Vitro Diagnostics Markets Globally Signals Upward Trajectory in Medical Laboratory Business

Growth in global IVD markets is indicator of increasing demand for clinical laboratory and anatomic pathology testing

During the next 24 months, the global in vitro diagnostics (IVD) market is predicted to exceed $50-billion in revenues. However, this robust growth has an upside and a downside for the clinical laboratories and pathology groups that purchase IVD analyzers, reagents, and consumables.

In a recent story in about the IVD industry, Frost & Sullivan, a global consulting and research firm, made predictions in different segments of the IVD market. It won’t surprise pathologists and clinical laboratory managers that the two fastest-growing segments are molecular and tissue diagnostics. (more…)

Introducing “Salivaomics” as the Basis for Cheap, Accurate Diagnostic Tests—Administered by Your Dentist!

Researchers at UCLA have published the foundation science to use saliva as the specimen for sophisticated diagnostic testing

Someday soon, when your dentist asks you to say “Ah”, he will then collect a saliva specimen and use a chairside point-of-care test (POCT) to screen you for any number of conditions and diseases. This is the goal of a research team at the University of California, Los Angeles (UCLA), who recently developed what they call the Salivaomics Knowledge Base (SKB).  It is a web-based data management system dedicated to help clinicians use saliva as a diagnostic tool.

(more…)

Laboratory Test and New Sepsis Alert System at Methodist North Hospital Saves Lives, Reduces Costs

New diagnostic protocols that use lactic acid test cut deaths from sepsis

Laboratory testing plays a key role in a new diagnostic protocol for sepsis that is saving lives at hospitals operated by Methodist Le Bonheur Healthcare in Tennessee. Since implementation of this new sepsis protocol, patient outcomes have improved significantly.

Leadership at Methodist North Hospital (MNH) decided to adopt the protocol after reading a study by Emanuel Rivers, M.D., Ph.D., of Henry Ford Medical Center, published in the New England Journal of Medicine,  that establishes criteria for identifying these patients.

(more…)

;